BLCO
Price
$14.91
Change
+$0.32 (+2.19%)
Updated
Sep 5, 01:54 PM (EDT)
Capitalization
5.17B
54 days until earnings call
CRL
Price
$165.11
Change
+$2.80 (+1.73%)
Updated
Sep 5, 01:58 PM (EDT)
Capitalization
7.99B
54 days until earnings call
Interact to see
Advertisement

BLCO vs CRL

Header iconBLCO vs CRL Comparison
Open Charts BLCO vs CRLBanner chart's image
Bausch + Lomb
Price$14.91
Change+$0.32 (+2.19%)
Volume$200
Capitalization5.17B
Charles River Laboratories International
Price$165.11
Change+$2.80 (+1.73%)
Volume$2.49K
Capitalization7.99B
BLCO vs CRL Comparison Chart in %
Loading...
BLCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLCO vs. CRL commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLCO is a Hold and CRL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (BLCO: $14.59 vs. CRL: $162.31)
Brand notoriety: BLCO and CRL are both not notable
BLCO represents the Pharmaceuticals: Other, while CRL is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLCO: 30% vs. CRL: 87%
Market capitalization -- BLCO: $5.17B vs. CRL: $7.99B
BLCO [@Pharmaceuticals: Other] is valued at $5.17B. CRL’s [@Medical Specialties] market capitalization is $7.99B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical Specialties] industry is $10.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green whileCRL’s FA Score has 1 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • CRL’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLCO and CRL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 3 TA indicator(s) are bullish while CRL’s TA Score has 7 bullish TA indicator(s).

  • BLCO’s TA Score: 3 bullish, 3 bearish.
  • CRL’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, CRL is a better buy in the short-term than BLCO.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а +0.27% price change this week, while CRL (@Medical Specialties) price change was -0.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.56%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +18.38%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was +7.02%, and the average quarterly price growth was +11.93%.

Reported Earning Dates

BLCO is expected to report earnings on Oct 29, 2025.

CRL is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.56% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($7.99B) has a higher market cap than BLCO($5.17B). CRL YTD gains are higher at: -12.075 vs. BLCO (-19.214). CRL has higher annual earnings (EBITDA): 528M vs. BLCO (454M). BLCO has more cash in the bank: 266M vs. CRL (183M). CRL has less debt than BLCO: CRL (2.79B) vs BLCO (4.96B). BLCO has higher revenues than CRL: BLCO (4.89B) vs CRL (4.03B).
BLCOCRLBLCO / CRL
Capitalization5.17B7.99B65%
EBITDA454M528M86%
Gain YTD-19.214-12.075159%
P/E RatioN/A577.05-
Revenue4.89B4.03B121%
Total Cash266M183M145%
Total Debt4.96B2.79B178%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLCOCRL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 8 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
BLCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTIF22.060.35
+1.60%
First Trust Bloomberg Infl Snstv Eq ETF
AGQI15.730.07
+0.45%
First Trust Active Gbl Qual Inc ETF
FTSD90.83-0.03
-0.03%
Franklin Short Duration US Govt ETF
SH38.27-0.32
-0.83%
ProShares Short S&P500
BPI40.28-0.71
-1.73%
Grayscale Bitcoin Premium Income ETF

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with RVTY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
-0.27%
RVTY - BLCO
45%
Loosely correlated
+2.81%
CRL - BLCO
43%
Loosely correlated
-0.01%
MTD - BLCO
43%
Loosely correlated
+1.51%
A - BLCO
43%
Loosely correlated
+2.60%
TMO - BLCO
42%
Loosely correlated
+1.02%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with RVTY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.01%
RVTY - CRL
61%
Loosely correlated
+2.81%
NOTV - CRL
58%
Loosely correlated
+1.27%
ICLR - CRL
58%
Loosely correlated
-2.03%
A - CRL
58%
Loosely correlated
+2.60%
AZTA - CRL
56%
Loosely correlated
+0.51%
More